vaccinia-cea(6d)-tricom vaccine

Vaccineexperimental

Clinical trial activity

10 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2000 (NCT00009958)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2002

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • vaccinia-cea(6d)-tricom vaccine
  • vaccinia-cea(6d)/tricom vaccine
  • vaccinia-tricom vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00450619Phase 2Feb 1, 2007National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00108732Phase 2Feb 1, 2006Eastern Cooperative Oncology Group, National Cancer Institute (NCI)
NCT00217373Phase 1Jun 1, 2005National Cancer Institute (NCI), Ohio State University
NCT00091039N/AAug 1, 2004National Cancer Institute (NCI)
NCT00088933Phase 1Jun 1, 2004Georgetown University, National Cancer Institute (NCI)
NCT00071942Phase 1Oct 1, 2003Harvard University, National Cancer Institute (NCI)
NCT00048893Phase 1/Phase 2 (Phase 2)Nov 1, 2002National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00052351Phase 2Sep 1, 2002National Cancer Institute (NCI)
NCT00022568Phase 1Aug 1, 2001Herbert Irving Comprehensive Cancer Center, National Cancer Institute (NCI)
NCT00009958Phase 1Nov 1, 2000Georgetown University, National Cancer Institute (NCI)
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government10932000
Georgetown UniversityAcademic/Hospital2012000
National Institutes of Health (NIH)Government2012002
Eastern Cooperative Oncology GroupAcademic/Hospital1012006
Harvard UniversityAcademic/Hospital1012003
Herbert Irving Comprehensive Cancer CenterAcademic/Hospital1112001
Ohio State UniversityAcademic/Hospital1012005
7 organizations
Page 1 / 1